Daiwa Securities Group Inc. Lowers Position in National Research Co. (NASDAQ:NRC)

Daiwa Securities Group Inc. lessened its position in National Research Co. (NASDAQ:NRC) by 3.1% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 37,468 shares of the company’s stock after selling 1,200 shares during the quarter. Daiwa Securities Group Inc. owned approximately 0.16% of National Research worth $860,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Precision Wealth Strategies LLC increased its position in National Research by 7.9% during the 1st quarter. Precision Wealth Strategies LLC now owns 5,623 shares of the company’s stock valued at $223,000 after buying an additional 413 shares in the last quarter. Russell Investments Group Ltd. increased its position in National Research by 6.3% during the 1st quarter. Russell Investments Group Ltd. now owns 14,348 shares of the company’s stock valued at $568,000 after buying an additional 847 shares in the last quarter. Rhumbline Advisers increased its position in National Research by 4.3% during the 2nd quarter. Rhumbline Advisers now owns 21,453 shares of the company’s stock valued at $492,000 after buying an additional 892 shares in the last quarter. Benjamin F. Edwards & Company Inc. increased its position in National Research by 860.2% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock valued at $45,000 after buying an additional 1,015 shares in the last quarter. Finally, CWM LLC increased its position in National Research by 889.7% during the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after buying an additional 1,041 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Stock Up 1.2 %

NRC stock opened at $21.90 on Monday. National Research Co. has a twelve month low of $20.41 and a twelve month high of $47.25. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.64. The firm has a market cap of $522.91 million, a PE ratio of 17.66 and a beta of 0.48. The business has a 50 day moving average of $22.67 and a 200 day moving average of $29.05.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.26 earnings per share for the quarter. The company had revenue of $35.02 million during the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%.

National Research Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.19%. The ex-dividend date is Friday, September 27th. National Research’s payout ratio is 38.71%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.